Author(s):
Rahul Choudhary, Sharuti, Prikshit Kumar, Inder Kumar
Email(s):
inder.93kumar@gmail.com
DOI:
10.52711/0975-4385.2026.00035 
Address:
Rahul Choudhary, Sharuti, Prikshit Kumar, Inder Kumar*
Minerva College of Pharmacy, Indora, Kangra, Himachal Pradesh, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 3,
Year - 2026
ABSTRACT:
Eucalyptus oil is a well-known natural product widely used for its therapeutic properties, particularly in the treatment of respiratory disorders. The present study aims to perform a preliminary phytochemical characterization of Eucalyptus oil obtained through hydrodistillation and to evaluate its potential implications in respiratory therapeutics. The extracted oil was subjected to standard qualitative phytochemical screening to identify major bioactive constituents. The results indicated the strong presence of terpenoids, along with significant amounts of flavonoids, tannins, and phenolic compounds. Glycosides were found to be moderately present, while alkaloids were detected only in trace amounts, and saponins were absent. The predominance of terpenoids, especially eucalyptol (1,8-cineole), plays a crucial role in the pharmacological activity of Eucalyptus oil. These compounds exhibit potent expectorant, bronchodilator, anti-inflammatory, and antimicrobial properties, making the oil highly effective in managing respiratory conditions such as cough, cold, bronchitis, and sinusitis. Furthermore, the presence of phenolic compounds and flavonoids enhances antioxidant activity, which helps in reducing oxidative stress and protecting respiratory tissues. Overall, the findings support the traditional use of Eucalyptus oil in respiratory care and highlight its potential as a natural therapeutic agent. Further studies involving detailed quantitative analysis, formulation development, and clinical evaluation are recommended to validate its efficacy and safety for broader medical applications.
Cite this article:
Rahul Choudhary, Sharuti, Prikshit Kumar, Inder Kumar. Preliminary Phytochemical Characterization of Eucalyptus Oil with Implications for Respiratory Therapeutics. Research Journal of Pharmacognosy and Phytochemistry. 2026; 18(3):243-8. doi: 10.52711/0975-4385.2026.00035
Cite(Electronic):
Rahul Choudhary, Sharuti, Prikshit Kumar, Inder Kumar. Preliminary Phytochemical Characterization of Eucalyptus Oil with Implications for Respiratory Therapeutics. Research Journal of Pharmacognosy and Phytochemistry. 2026; 18(3):243-8. doi: 10.52711/0975-4385.2026.00035 Available on: https://rjpponline.org/AbstractView.aspx?PID=2026-18-3-5
REFERENCE:
1. Tomé M, Almeida MH, Barreiro S, Branco MR, Deus E, Pinto G, et al. Opportunities and challenges of Eucalyptus plantations in Europe: The Iberian Peninsula experience. Eur J For Res. 2021; 140(3): 489–510.
2. Lee SH, Lum WC, Antov P, Krišt’ák L, Rahandi Lubis MA, Fatriasari W. Eucalyptus. Springer; 2024. 554–560 p.
3. Shiekh RA El, Atwa AM, Elgindy AM, Mustafa AM, Senna MM, Alkabbani MA, et al. Therapeutic applications of eucalyptus essential oils: RA El Shiekh et al. Inflammopharmacology. 2025; 33(1): 163–82.
4. Hirsch H, Allsopp MH, Canavan S, Cheek M, Geerts S, Geldenhuys CJ, et al. Eucalyptus camaldulensis in South Africa–past, present, future. Trans R Soc South Africa. 2020; 75(1): 1–22.
5. Alemayehu A, Melka Y. Small scale eucalyptus cultivation and its socioeconomic impacts in Ethiopia: A review of practices and conditions. Trees, For People. 2022; 8(2): 100269.
6. Hutapea FJ, Weston CJ, Mendham D, Volkova L. Sustainable management of Eucalyptus pellita plantations: A review. For Ecol Manage. 2023; 537(6): 120941.
7. Almas I, Innocent E, Machumi F, Kisinza W. Chemical composition of essential oils from Eucalyptus globulus and Eucalyptus maculata grown in Tanzania. Sci African. 2021; 12(3): e00758.
8. Khedkar DD. Plant products and essential oil therapy for treatment of new and emerging viruses. In: Fighting multidrug resistance with herbal extracts, essential oils and their components. Elsevier; 2025. p. 391–419.
9. Leigh-de Rapper S, Viljoen A, van Vuuren S. Essential oil blends: The potential of combined use for respiratory tract infections. Antibiotics. 2021;10(12): 1517.
10. GabAllah M, Shaker K, Abulhamd AT, El-Shesheny R. Synergistic Antiviral Effects of Combined Fractions from Eucalyptus camaldulensis Against SARS-CoV-2. Egypt J Chem. 2025; 68(13): 1–13.
11. Becker LC, Akinsulie A, Bergfeld WF, Belsito D V, Hill RA, Klaassen CD, et al. Safety assessment of Eucalyptus globulus (eucalyptus)-derived ingredients as used in cosmetics. Int J Toxicol. 2023; 42(1_suppl): 57S-92S.
12. Singh Y, Das KK, Thelly MT, Kumar B, Roy A. Phytochemical study and in vitro anti-diabetic activity of eucalyptus and lemon oils. Drug Anal Res. 2022; 5(2): 22–33.
13. Mondal M, Quispe C, Sarkar C, Bepari TC, Alam MJ, Saha S, et al. Analgesic and anti-inflammatory potential of essential oil of Eucalyptus camaldulensis leaf: in vivo and in silico studies. Nat Prod Commun. 2021;16(4): 1934578X211007634.
14. Sharma AD, Inderjeet K. Molecular docking and pharmacokinetic screening of eucalyptol (1, 8 cineole) from eucalyptus essential oil against SARS-CoV-2. Not Sci Biol. 2020; 12(3): 536–45.
15. Juergens LJ, Worth H, Juergens UR. New perspectives for mucolytic, anti-inflammatory and adjunctive therapy with 1, 8-cineole in COPD and asthma: review on the new therapeutic approach. Adv Ther. 2020; 37(5): 1737–53.
16. Hussain HA, Islam M, Saeed H, Ahmad A, Hussain A, Rafay MZ. Insight to phytochemical investigation and anti-hyperlipidemic effects of Eucalyptus camaldulensis leaf extract using in vitro, in vivo and in silico approach. J Biomol Struct Dyn. 2025; 43(1): 325–47.
17. Yao B, He B, Peng J, Song X, Zhao R, Sun Y, et al. The comprehensive review of eucalyptol: synthesis, metabolism, and therapeutic applications in disease treatment. Mol Biol Rep. 2025; 52(1): 346.
18. Kheder DA, Al-Habib OAM, Gilardoni G, Vidari G. Components of volatile fractions from Eucalyptus camaldulensis leaves from Iraqi–Kurdistan and their potent spasmolytic effects. Molecules. 2020; 25(4): 804.
19. Bem AA, Adamu H, Bem LS. Comparative Phytochemical Analysis and Medicinal Properties of Neem (Azadirachta indica) and Eucalyptus (Eucalyptus globulus) Plant. Sahel J Life Sci FUDMA. 2025; 3(2): 304–10.
20. Asif M, Saleem M, Saadullah M, Yaseen HS, Al Zarzour R. COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. Inflammopharmacology. 2020; 28(5): 1153–61.
21. Aswandi A, Kholibrina CR, Kuspradini H. Phytochemical, essential oils and product applications from Eucalyptus. In: Eucalyptus: Engineered Wood Products and Other Applications. Springer; 2023. p. 163–83.
22. Okhale SE, Oladosu PO, Aboh MI, Imoisi C, Gana JJ. In-vitro evaluation of Eucalyptus citriodora leaf essential oil and extracts on selected pathogens implicated in respiratory tract infections. Int J Pharmacogn. 2022; 9(4): 195–201.
23. Surbhi, Kumar A, Singh S, Kumari P, Rasane P. Eucalyptus: phytochemical composition, extraction methods and food and medicinal applications. Adv Tradit Med. 2023; 23(2): 369–80.
24. Singh J, Javed DS, Yadav R, Verma AK, Upadhyay DK. Review on eucalyptus: phytochemical profile, Extraction Techniques, And Pharmacological Applications In Food And Medicine. Acta Biomed. 2024; 95(1): 334–44.
25. Sharma AD, Farmaha M, Kaur I, Singh N. Phytochemical analysis using GC-FID, FPLC fingerprinting, antioxidant, antimicrobial, anti-inflammatory activities analysis of traditionally used Eucalyptus globulus essential oil. Drug Anal Res. 2021; 5(1): 26–38.
26. El-Shiekh RA, Okba MM, Mandour AA, Kutkat O, Elshimy R, Nagaty HA, et al. Eucalyptus oils phytochemical composition in correlation with their newly explored anti-SARS-CoV-2 potential: in vitro and in silico approaches. Plant Foods Hum Nutr. 2024; 79(2): 410–6.
27. Mostafa-Hedeab G, Hegazy A, Mostafa I, Eissa IH, Metwaly AM, Elhady HA, et al. In vitro antiviral activities of thymol and Limonin against influenza a viruses and SARS-CoV-2. Sci Rep. 2025; 15(1): 22587.
28. Chalannavar R. Role of botanical essential oils as a therapy for controlling coronavirus (SARS-CoV-2) disease (Covid-19). Int J Res Sci Innov. 2021; 8(4): 105–18.
29. Sri PK, Reddy TUK, Sony B, Sandhya A, Rajyalakshmi KG, Sindhu G, et al. Preparation And Evaluation Of Polyherbal Scented Candle Using Volatile Oils Extracted By Enfleurage Method. Indones J Heal Sci Res Dev. 2023; 6(1): 38–48.
30. Almeida HHS, Crugeira PJL, Amaral JS, Rodrigues AE, Barreiro MF. Disclosing the potential of Cupressus leylandii AB Jacks & Dallim, Eucalyptus globulus Labill., Aloysia citrodora Paláu, and Melissa officinalis L. hydrosols as eco-friendly antimicrobial agents. Nat Products Bioprospect. 2024; 14(1): 1.